- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Evogliptin Pioglitazone, Pioglitazone, Evogliptin
Total 612 results
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2United States
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruitingInsulin Resistance | Type2diabetes
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedInsulin Resistance | Intermittent Claudication | Arterial Occlusive DiseaseUnited States
-
TakedaCompleted
-
St. Louis UniversityWithdrawnInsulin Resistance | Prostate CancerUnited States
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)CompletedRheumatoid ArthritisUnited States
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
TakedaCompleted
-
Skane University HospitalMedical Research Council; Skane County Council Research & Development FoundationCompletedType 2 Diabetes | Secondary Drug FailureSweden
-
Mylan Pharmaceuticals IncCompleted
-
Torrent Pharmaceuticals LimitedCompleted
-
National Cancer Institute (NCI)TerminatedStage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oral Cavity Squamous Cell Carcinoma... and other conditionsUnited States
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, Argentina
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Oregon Health and Science UniversityCompleted
-
VA Office of Research and DevelopmentCompleted
-
Stanford UniversityCompletedObesity | Metabolic Syndrome | Impaired Glucose ToleranceUnited States
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
National Institute on Aging (NIA)Takeda Pharmaceuticals North America, Inc.Completed
-
Boehringer IngelheimCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedMetabolic Syndrome | Insulin Resistance | Type 2 DiabetesUnited States
-
VA Office of Research and DevelopmentCompletedNonalcoholic SteatohepatitisUnited States
-
Kurume UniversityUnknownTo Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingJapan
-
National Center for Research Resources (NCRR)CompletedDiabetes Mellitus | Insulin ResistanceUnited States
-
Boryung Pharmaceutical Co., LtdCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Daiichi Sankyo Co., Ltd.Completed
-
TakedaCompleted
-
Shiga UniversityOsaka University; Kanazawa Medical University; Nagahama Red Cross Hospital; Nagahama... and other collaboratorsUnknownType 2 Diabetes MellitusJapan
-
TakedaCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Chile, Mexico, Puerto Rico
-
TakedaCompletedDiabetes MellitusChina, Taiwan, Korea, Republic of, Malaysia
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
TakedaCompleted
-
Dong-A ST Co., Ltd.UnknownDiabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Metabolic Disease | Renal DiseaseKorea, Republic of
-
Parke-DavisCompletedDiabetes Mellitus | AtherosclerosisUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Metabolic Solutions Development CompanyCompletedAlzheimer's DiseaseUnited States
-
The University of Texas Health Science Center at...CompletedHealthy | Type 2 Diabetes | Impaired Glucose ToleranceUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Austria, Greece, Hungary, Japan, Portugal, Romania, Spain
-
National Cancer Institute (NCI)TerminatedNon-Small-Cell Lung CancerUnited States
-
Yonsei UniversityCompletedAtherosclerosis | Insulin Resistance | Kidney TransplantationKorea, Republic of
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 and Hepatitis C Co-InfectionUnited States
-
GlaxoSmithKlinePopulation Health Research InstituteTerminatedDiabetes Mellitus, Type 2United States, Germany, Russian Federation, Netherlands, South Africa, Sweden, Canada, Norway, United Kingdom, Latvia, Thailand, Colombia, India, Peru, Romania, Pakistan, Slovakia, Finland, Chile, Denmark, Argentina, Mexico, Czech Republic and more
-
Kyung Hee University Hospital at GangdongDong-A ST Co., Ltd.UnknownDiabetes Mellitus, Type 2 | Bone Diseases, MetabolicKorea, Republic of